New Mexico
How Enright v. Eli Lilly & Co. applies in New Mexico: state-specific rules, key cases, and bar exam notes for Other.
New Mexico follows the principle established in Enright v. Eli Lilly & Co. regarding the admissibility of evidence and expert testimony related to pharmaceutical liability. New Mexico courts emphasize the necessity for a clear connection between the expert's qualifications and the testimony offered, particularly in product liability cases.
In New Mexico, the rule derived from Enright requires that expert testimony must be based on sufficient facts or data, and the expert must possess the necessary qualifications to speak on the relevant issues, particularly involving complex scientific or medical matters.
The court ruled that lack of reliable expert testimony can lead to dismissal of a product liability claim against manufacturers.
In this case, the New Mexico Supreme Court emphasized that the admissibility of expert testimony is pivotal in establishing causation within product liability cases.
New Mexico's approach closely mirrors federal standards set forth in Daubert v. Merrell Dow Pharmaceuticals, which require that expert testimony be both relevant and reliable. However, New Mexico's specific case law also places a strong emphasis on the qualifications of the expert to ensure that their opinions are not only scientifically valid but also applicable to the facts of the case.
Understanding the principles from Enright v. Eli Lilly is significant for questions related to expert testimony and evidence on the New Mexico bar exam. Students should focus on state-specific nuances in expert qualifications and admissibility standards.